Arthritis, Rheumatoid

"Arthritis, Rheumatoid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.

Descriptor ID	D001172
MeSH Number(s)	C05.550.114.154 C05.799.114 C17.300.775.099 C20.111.199
Concept/Terms	Arthritis, Rheumatoid Arthritis, Rheumatoid Rheumatoid Arthritis

Below are MeSH descriptors whose meaning is more general than "Arthritis, Rheumatoid".

Diseases [C]
Musculoskeletal Diseases [C05]
Joint Diseases [C05.550]
Arthritis [C05.550.114]
Arthritis, Rheumatoid [C05.550.114.154]
Rheumatic Diseases [C05.799]
Arthritis, Rheumatoid [C05.799.114]
Skin and Connective Tissue Diseases [C17]
Connective Tissue Diseases [C17.300]
Rheumatic Diseases [C17.300.775]
Arthritis, Rheumatoid [C17.300.775.099]
Immune System Diseases [C20]
Autoimmune Diseases [C20.111]
Arthritis, Rheumatoid [C20.111.199]

Below are MeSH descriptors whose meaning is related to "Arthritis, Rheumatoid".

Below are MeSH descriptors whose meaning is more specific than "Arthritis, Rheumatoid".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Arthritis, Rheumatoid" by people in this website by year, and whether "Arthritis, Rheumatoid" was a major or minor topic of these publications.

Bar chart showing 256 publications over 29 distinct years, with a maximum of 21 publications in 2015

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	3	0	3
1996	2	1	3
1998	2	0	2
1999	0	2	2
2000	1	0	1
2001	0	2	2
2002	2	2	4
2004	1	0	1
2005	2	1	3
2006	2	3	5
2007	5	1	6
2008	10	1	11
2009	7	1	8
2010	14	4	18
2011	5	3	8
2012	11	0	11
2013	16	3	19
2014	12	1	13
2015	20	1	21
2016	16	3	19
2017	13	0	13
2018	12	0	12
2019	19	0	19
2020	6	1	7
2021	6	1	7
2022	8	0	8
2023	12	0	12
2024	11	0	11
2025	6	1	7

Below are the most recent publications written about "Arthritis, Rheumatoid" by people in Profiles.

Choi H, Han K, Jung JH, De Soyza A, Kim H, Shin DW, Lee H. Impact of rheumatoid arthritis, seropositivity and disease-modifying anti-rheumatic drugs on mortality risk in bronchiectasis. Ther Adv Respir Dis. 2025 Jan-Dec; 19:17534666251360071.

View in: PubMed
Litman HJ, Sheffield KM, Pugach O, Shan M, Lakin P, Cui ZL, Curtis SE, Johnston JA, Harrold LR. Applying Bias Correction Methods to Build Hybrid Controls Using Real-World Patients for a Phase IIb Randomized Controlled Trial of Baricitinib for Rheumatoid Arthritis. Pharm Stat. 2025 Jul-Aug; 24(4):e70020.

View in: PubMed
Lee D, Jeon KH, Jung J, Han K, Cho MH, Cho IY, Shin DW. Urological cancer risk in patients with rheumatoid arthritis compared to matched controls: a nationwide cohort study. Rheumatology (Oxford). 2025 Jun 01; 64(6):3458-3467.

View in: PubMed
Avouac J, Kay J, Choy E. Personalised treatment of rheumatoid arthritis based on cytokine profiles and synovial tissue signatures: potentials and challenges. Semin Arthritis Rheum. 2025 Aug; 73:152740.

View in: PubMed
Winthrop KL, Bathon J, Kerschbaumer A, Isaacs JD, Mease P, Gottenberg JE, Crow MK, Kay J, Crofford L, Baraliakos X, Bykerk V, Siebert S, Kloppenburg M, Aletaha D, McInnes IB, Huizinga T, Voll R, Gravallese EM, Breedveld FC, van Vollenhoven R, Smolen JS. Chasing the target: reports from the Advances in Targeted Therapies meeting, 2024. Ann Rheum Dis. 2025 Jun; 84(6):927-936.

View in: PubMed
Kim BG, Lee H, Eun Y, Han K, Jung JH, Choi H, Kim H, Shin DW. Association between rheumatoid arthritis and interstitial lung disease and impact of serologic status: a large-scale longitudinal study. Sci Rep. 2025 Feb 10; 15(1):4885.

View in: PubMed
Fukui S, Winkelmayer WC, Tedeschi SK, Marrugo J, Guan H, Harrold L, Litman HJ, Shinozaki T, Solomon DH. Disease activity of rheumatoid arthritis and kidney function decline: a large prospective registry study. Ann Rheum Dis. 2025 Feb; 84(2):201-209.

View in: PubMed
Harrold LR, Bingham CO, Pope JE, O'Brien J, Moore PC, Roberts-Toler C, Yu M, Sweet LL, Shelbaya A, Masri KR. Effectiveness of tofacitinib versus tumor necrosis factor inhibitors and in those receiving tofacitinib as different lines of therapy in patients with rheumatoid arthritis: results from the United States CorEvitas Rheumatoid Arthritis Registry. Clin Rheumatol. 2025 Feb; 44(2):635-648.

View in: PubMed
Baker JF, Reed G, Mikuls TR, Thiele GM, Pappas DA, Charles-Schoeman C, Guma M, Harrold LR, Curtis JR, Kremer JM. Metabolic Syndrome, Adipokines, and Response to Advanced Therapies in Rheumatoid Arthritis. Arthritis Rheumatol. 2025 Mar; 77(3):263-271.

View in: PubMed
Spandorfer R, Kane K, Pappas DA, Kremer J, Reed G, Curtis JR, Navarro-Mill?n I. New onset work disability in rheumatoid arthritis is an underrecognized cardiovascular risk factor: A retrospective cohort study using the CorEvitas registry. Semin Arthritis Rheum. 2025 02; 70:152559.

View in: PubMed

People

Explore

Similar Concepts

Top Journals